Siddarth Satish serves as Vice President of Digital Innovation for the Surgical Technologies business at Stryker. Previously, he was the Chief Executive Officer of Gauss Surgical, a venture-backed healthcare AI company acquired by Stryker in 2021. Siddarth founded Gauss in 2011 and served as its Chief Technology Officer until he was appointed CEO in 2015. While at Gauss, he initiated the development of Triton, a computer vision application for monitoring surgical blood loss, and led the company through De Novo clearance from the U.S. Food and Drug Administration (FDA) in 2014 and early market launch. Under Siddarth’s commercial leadership, Triton was widely adopted by US health systems, surpassing 250,000 surgical procedures annually by 2019 and winning regulatory approvals in the EU and Asia Pacific regions. In 2018, Triton received the Apple Design Award, which recognizes the best in design, innovation, and technology on Apple platforms. In his operating roles, Siddarth raised $60 million in venture capital financing and architected the spinoff of several home diagnostics technologies developed by Gauss in response to the COVID-19 pandemic. From 2011 to 2013, Siddarth served as an Entrepreneur-in-Residence at StartX, Stanford University’s Startup Accelerator. Prior to founding Gauss, Siddarth held a SIMdesign fellowship in the Department of Surgery at Stanford University and performed research in computer-aided drug discovery at Gilead Sciences. Siddarth received a B.S. in Chemical Engineering from the University of California, Berkeley, and an M.S. in Bioengineering from the UC Berkeley-UCSF Joint Graduate Group in Bioengineering. He holds over 50 issued or pending patents in the fields of surgery, diagnostics, and computer vision and was named to the Forbes 30 Under 30 list in Healthcare.